Cargando…
Treatment patterns and outcomes for patients with newly diagnosed glioblastoma multiforme: a retrospective cohort study
AIM: Investigate real-world outcomes and healthcare utilization of patients with glioblastoma multiforme (GBM) related to O(6)-methylguanine DNA methyltransferase (MGMT) promoter testing and methylation. PATIENTS & METHODS: US Oncology Network data were analyzed for patients receiving first-line...
Autores principales: | Annavarapu, Srinivas, Gogate, Anagha, Pham, Trang, Davies, Kalatu, Singh, Prianka, Robert, Nicholas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Future Medicine Ltd
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8461754/ https://www.ncbi.nlm.nih.gov/pubmed/34378977 http://dx.doi.org/10.2217/cns-2021-0007 |
Ejemplares similares
-
Survival with dacarbazine and fotemustine in newly diagnosed glioblastoma multiforme
por: Fazeny-Dörner, B, et al.
Publicado: (2003) -
The timing of cranial radiation in elderly patients with newly diagnosed glioblastoma multiforme
por: Lai, Rose, et al.
Publicado: (2010) -
Infrared Thermography in Surgery of Newly Diagnosed Glioblastoma Multiforme: A Technical Case Report
por: Naydenov, Emanuil, et al.
Publicado: (2017) -
Improved Outcomes with Intensity Modulated Radiation Therapy Combined with Temozolomide for Newly Diagnosed Glioblastoma Multiforme
por: Aherne, Noel J., et al.
Publicado: (2014) -
Prognostic significance of concomitant radiotherapy in newly diagnosed glioblastoma multiforme: a multivariate analysis of 116 patients
por: Okumus, Nilgun Ozbek, et al.
Publicado: (2012)